Sep. 2 at 6:45 PM
$PTIX PTIX – Potential Upcoming News/PR Catalysts
10-Q Filing – financial update & compliance check
Completion of Enrollment – 10@ dose cohort in PT00114 Phase 1 trial
Topline Data – safety, tolerability, and PK results expected by end of month
👉 Even if they drop just one of these 3 PRs, it could be a strong short-term catalyst for PTIX.